Anaphylactic Shock and Cardiac Arrest Secondary to Aprepitant
- PMID: 32796161
- DOI: 10.1097/MJT.0000000000001133
Anaphylactic Shock and Cardiac Arrest Secondary to Aprepitant
References
-
- Kreys ED, Kim TY, Delgado A, et al. Impact of cancer supportive care pathways compliance on emergency department visits and hospitalizations. J Oncol Pract. 2014;10:168–173.
-
- Craver C, Gayle J, Balu S, et al. Clinical and economic burden of chemotherapy-induced nausea and vomiting among patients with cancer in a hospital outpatient setting in the United States. J Med Econ. 2011;14:87–98.
-
- Kim H-K, Hsieh R, Chan A, et al. Impact of CINV in earlier cycles on CINV and chemotherapy regimen modification in subsequent cycles in Asia Pacific clinical practice. Support Care Cancer. 2015;23:293–300.
-
- du Bois A, Meerpohl HG, Kommoss FGM, et al. Course, patterns, and risk-factors for chemotherapy-induced emesis in cisplatin-pretreated patients: a study with ondansetron. Eur J Cancer. 1992;28:450–457.
-
- Navari RM. 5-HT3 receptors as important mediators of nausea and vomiting due to chemotherapy. Biochim Biophys Acta. 1848;2015:2738–2746.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical